Geode Capital Management’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-984,035
Closed -$2.94M 5092
2022
Q1
$2.94M Sell
984,035
-4,020
-0.4% -$8.85K ﹤0.01% 3060
2021
Q4
$1.26M Buy
988,055
+162,900
+20% +$326K ﹤0.01% 3593
2021
Q3
$1.86M Sell
825,155
-25,023
-3% -$89.9K ﹤0.01% 3380
2021
Q2
$4.84M Buy
850,178
+487,308
+134% +$3.24M ﹤0.01% 2930
2021
Q1
$2.28M Hold
362,870
﹤0.01% 3198
2020
Q4
$2.84M Buy
+362,870
New +$3.21M ﹤0.01% 2889

Geode Capital Management's TLMD Position: Q2 2022 in Review

Geode Capital Management sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q2 2022, closing a stake of 984,035 shares — an estimated $2.94M sold.

Geode Capital Management first reported a position in TLMD in Q4 2020 and held it in 6 quarters. The position peaked at $4.84M in Q2 2021. 0 funds tracked by Wall St. Rank hold TLMD as of Q2 2022.

  • Geode Capital Management reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
  • Geode Capital Management sold 984,035 SOC Telemed, Inc. Class A Common Stock shares in Q2 2022, an estimated $2.94M.
  • Geode Capital Management first reported a position in SOC Telemed, Inc. Class A Common Stock in Q4 2020 and held it in 6 quarters.
  • Geode Capital Management's SOC Telemed, Inc. Class A Common Stock position peaked at $4.84M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q2 2022.

Based on Geode Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.